Thursday, 19 September 2019

Garth Tierney is executive VP of INC CRO

04 March 2013 | News | By BioSpectrum Bureau

Mr Garth Tierney - The new executive vice president, Asia Pacific, INC Research

Mr Garth Tierney - The new executive vice president, Asia Pacific, INC Research

Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible for driving the strategic development and overall growth of the CRO. Mr Tierney, who served previously as the company's regional general manager, Australia and South East Asia, co-founded Trident Clinical Research, an Australian-based CRO, which was acquired by INC Research in 2011 after 14 years of operation.

He holds a graduate diploma in business administration and a Bachelor of Science in pharmacology from the University of Adelaide and the University of New South Wales, Australia, respectively, and worked in hypertension research for several years before joining the pharmaceutical industry. During this time, he published various papers and won the Whelan prize (awarded by ASCEPT).

Mr Tierney succeeds Dr Kelvin Logan, who will retire in April. Dr Logan joined INC Research in 2002 as the company's first employee outside of North America and played an instrumental role in growing the EMEA and Asia/Pacific regions to 2,200 staff and 43 offices, helping to catapult INC Research into one of the top global CROs that has retained its strong global focus.

"INC Research is experiencing tremendous opportunity to help drug developers navigate the diverse and complex landscape of conducting trials across the Asia/Pacific region, especially as many countries are poised to significantly increase their investment in clinical research," said Mr Tierney. "This is an exciting time within this developing region and I look forward to helping our customers leverage the benefits of Asia/Pacific to advance their clinical development programs."

"Asia Pacific is a key focus area for INC Research because our customers are demanding a strong partner for on-the-ground expertise to help design and execute custom research programs. Garth is the obvious choice to take over the helm in the region based on his extensive knowledge and operational prowess," said COO Alistair Macdonald. "Additionally, I'd like to personally thank Kelvin for all of his tremendous accomplishments in building the company's Asia Pacific operations into what they are today."

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls